◆ 会议时间：2024年6月19-21日
◆ 会议地点：美国 菲尼克斯

◆ 会议简介：

TVT 2024(结构性心脏病峰会)将于2024年6月19-21日在美国菲尼克斯举行，会议由美国心血管研究基金会(CRF)主办。 TVT-结构性心脏病峰会，是专为多学科的临床从业者、医疗保健专业人士宣、院士、工程师和科学家等人士而设计 - 包括临床心脏病专家，心脏成像专家（尤其是超声和CT），心脏和血管外科医生，电生理学家，心力衰竭专家，执业护士和医师助理，导管室技术人员，其他医疗保健专业人员以及对瓣膜和结构性心脏病感兴趣的医疗器械界人士。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

TVT 2024 - Transcatheter Valve Therapy (TVT) Structural Heart Summit
Date: June 19-21, 2024
Venue: Phoenix Convention Center - West, Phoenix, AZ, USA

Organized by: Cardiovascular Research Foundation (CRF)

Transcatheter Valve Therapy (TVT): The Structural Heart Summit convenes leaders in the field to present four days of world-class education and global networking.

The maturation of transcatheter aortic valve replacement (TAVR) and the rapid adoption of transcatheter mitral and tricuspid therapies have changed the treatment landscape, expanding options for patients with structural heart disease (SHD). The central mission of TVT is to provide health professionals involved in care of SHD patients comprehensive insight and updates, annually, on a rapidly evolving field of minimally invasive treatment options for patients with structural heart disease.

Treatment of structural heart disease is truly multidisciplinary, integrating noninvasive cardiac imaging, surgical therapies, heart failure management, and novel transcatheter approaches — underscoring the importance of professional continuing education.

By the end of this course, participants should be able to:

• Discuss the evaluation and management of patients with valvular and structural heart disease.
• Assess the imaging modalities available for diagnosing valvular and structural heart disease.
• Describe current and future therapeutic options for valvular and structural heart disease.
• Understand the skills necessary to perform transcatheter valve therapies, left atrial appendage (LAA) closure, and patent foramen ovale (PFO) closure.

TVT is designed for a multidisciplinary audience that includes anyone interested in the treatment of valvular and structural heart disease. This includes:

• Biomedical engineers
• Cardiac and vascular surgeons
• Cardiac imaging specialists (especially echo and CT)
• Cath lab technologists
• Clinical cardiologists
• Electrophysiologists
• Fellows
• Heart failure specialists
• Interventional cardiologists
• Medical device experts
• Nurse practitioners
• Physician assistants
• Research scientists

◆ 参会对象：临床心脏病专家/医生，心脏成像专家，心脏和血管外科医生，电生理学家，心力衰竭专家，执业护士和医师助理，导管室技术人员，其他医疗保健专业人员以及对瓣膜和结构性心脏病感兴趣的医疗器械界人士。